About Fuyingguan
Fuyingguan is a company based in Qinhuangdao (China) founded in 2021. Fuyingguan has raised $4.12 million across 1 funding round from investors including Huatai Securities.
- Headquarter Qinhuangdao, China
- SectorsHealthcare
- Total Equity Funding$4.12M (USD)
in 1 rounds
- Latest Funding Round$4.12M (USD), Series A
Dec 2024
- Investors
Funding Insights of Fuyingguan
Fuyingguan has successfully raised a total of $4.12M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.12 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.12M
- Total Rounds 1
- Last Round Series A — $4.12M
- First Round $4.12M
(Dec 2024)
- Investors Count 1
All 1 funding rounds of Fuyingguan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2024 | $4.12M | Series A | – | – |
1 investors in total: 1 institutional.
Investors in Fuyingguan
Fuyingguan has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Huatai Securities.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Financial services provider | 1991 | htsc.com.cn | Nanjing, China |
Investor details for Fuyingguan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Fuyingguan
2 dated milestones of Fuyingguan across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Fuyingguan is founded.
- Funding First funding round of $4.1M.
Similar companies to Fuyingguan
10 companies that operate in the same segment as Fuyingguan (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fuyingguan
Fuyingguan was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Fuyingguan is headquartered in Qinhuangdao, China. It is registered at Qinhuangdao, Hebei, China.
Fuyingguan is a funded company, having raised a total of $4.12M across 1 funding round to date. The company's 1st funding round was a Series A of $4.12M, raised on Dec 2024.
Fuyingguan was established in 2021 in Qinhuangdao, China, within the health and wellness sector. Nutritional supplements and food products are produced by the company. A specialized technology is provided for developing sea cucumber peptide-based items, which target improvements in health and wellness. Operations focus on manufacturing processes tailored to these peptide-derived formulations.
Fuyingguan has 1 investor. Key investors include Huatai Securities.